GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Recordati SpA (FRA:RER1) » Definitions » Cyclically Adjusted FCF per Share

Recordati SpA (FRA:RER1) Cyclically Adjusted FCF per Share : €1.03 (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Recordati SpA Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Recordati SpA's adjusted free cash flow per share for the three months ended in Mar. 2024 was €0.679. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €1.03 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Recordati SpA's average Cyclically Adjusted FCF Growth Rate was -0.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 20.60% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Recordati SpA was 25.60% per year. The lowest was 1.20% per year. And the median was 13.30% per year.

As of today (2024-06-06), Recordati SpA's current stock price is €47.84. Recordati SpA's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €1.03. Recordati SpA's Cyclically Adjusted Price-to-FCF of today is 46.45.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Recordati SpA was 91.17. The lowest was 36.75. And the median was 56.37.


Recordati SpA Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Recordati SpA's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Recordati SpA Cyclically Adjusted FCF per Share Chart

Recordati SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.56 0.76 0.98 0.99

Recordati SpA Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.05 1.08 0.99 0.99 1.03

Competitive Comparison of Recordati SpA's Cyclically Adjusted FCF per Share

For the Drug Manufacturers - General subindustry, Recordati SpA's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Recordati SpA's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Recordati SpA's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Recordati SpA's Cyclically Adjusted Price-to-FCF falls into.



Recordati SpA Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Recordati SpA's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.679/120.2000*120.2000
=0.679

Current CPI (Mar. 2024) = 120.2000.

Recordati SpA Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 0.146 100.093 0.175
201409 0.272 99.814 0.328
201412 0.165 99.721 0.199
201503 0.171 99.814 0.206
201506 0.289 100.279 0.346
201509 0.370 100.000 0.445
201512 0.192 99.814 0.231
201603 0.287 99.600 0.346
201606 0.237 99.900 0.285
201609 0.346 100.100 0.415
201612 0.174 100.300 0.209
201703 0.382 101.000 0.455
201706 -0.913 101.100 -1.085
201709 0.165 101.200 0.196
201712 0.136 101.200 0.162
201803 0.334 101.800 0.394
201806 0.369 102.400 0.433
201809 0.449 102.600 0.526
201812 0.154 102.300 0.181
201903 0.219 102.800 0.256
201906 0.141 103.100 0.164
201909 0.488 102.900 0.570
201912 -1.445 102.800 -1.690
202003 0.333 102.900 0.389
202006 0.221 102.900 0.258
202009 0.356 102.300 0.418
202012 0.391 102.600 0.458
202103 0.276 103.700 0.320
202106 0.423 104.200 0.488
202109 0.692 104.900 0.793
202112 0.541 106.600 0.610
202203 0.467 110.400 0.508
202206 0.316 112.500 0.338
202209 0.546 114.200 0.575
202212 0.417 119.000 0.421
202303 0.432 118.800 0.437
202306 0.691 119.700 0.694
202309 -0.904 120.300 -0.903
202312 0.268 119.700 0.269
202403 0.679 120.200 0.679

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Recordati SpA  (FRA:RER1) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Recordati SpA's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=47.84/1.03
=46.45

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Recordati SpA was 91.17. The lowest was 36.75. And the median was 56.37.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Recordati SpA Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Recordati SpA's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Recordati SpA (FRA:RER1) Business Description

Industry
Traded in Other Exchanges
Address
Via Matteo Civitali 1, MIlan, ITA, 20148
Recordati SpA is a drug manufacturing company that focuses on specialty pharmaceuticals. The company produces and promotes medicines globally that focus on primary-care therapies and rare diseases. Recordati uses strategic partnerships as part of its long-term growth. The vast majority of the company's revenue is generated in Italy, followed by the United States, France, and Germany. Recordati reports two operating segments: Specialty and Primary care and Rare diseases. The bulk of the company's profit is derived from its specialty and primary care segment, which includes the production of active ingredients.

Recordati SpA (FRA:RER1) Headlines

No Headlines